Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $30.00 by Analysts at KeyCorp

Acadia Healthcare (NASDAQ:ACHC) had its target price lowered by equities research analysts at KeyCorp from $35.00 to $30.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. KeyCorp’s target price indicates a potential upside of 97.69% from the stock’s previous close.

A number of other equities analysts have also issued reports on ACHC. Raymond James Financial set a $22.00 target price on shares of Acadia Healthcare in a research report on Friday, November 7th. Royal Bank Of Canada reduced their price objective on Acadia Healthcare from $28.00 to $22.00 and set an “outperform” rating on the stock in a report on Wednesday, November 12th. Mizuho decreased their price objective on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 13th. UBS Group dropped their target price on Acadia Healthcare from $31.00 to $28.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Finally, Bank of America cut Acadia Healthcare from a “buy” rating to a “neutral” rating and decreased their price target for the company from $27.00 to $25.00 in a report on Wednesday, September 10th. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $32.36.

Acadia Healthcare Price Performance

ACHC traded down $0.48 during trading on Tuesday, hitting $15.18. The company’s stock had a trading volume of 124,797 shares, compared to its average volume of 2,361,259. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $1.40 billion, a price-to-earnings ratio of 10.03, a price-to-earnings-growth ratio of 4.56 and a beta of 0.97. The firm’s 50 day moving average price is $22.58 and its two-hundred day moving average price is $22.57. Acadia Healthcare has a 12 month low of $15.15 and a 12 month high of $47.08.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The company had revenue of $851.57 million during the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The firm’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period last year, the company posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Sell-side analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. CANADA LIFE ASSURANCE Co increased its stake in Acadia Healthcare by 38.6% in the third quarter. CANADA LIFE ASSURANCE Co now owns 92,269 shares of the company’s stock valued at $2,264,000 after purchasing an additional 25,710 shares in the last quarter. Verition Fund Management LLC increased its position in shares of Acadia Healthcare by 32.1% in the 3rd quarter. Verition Fund Management LLC now owns 205,620 shares of the company’s stock valued at $5,091,000 after buying an additional 50,016 shares in the last quarter. Prelude Capital Management LLC raised its stake in Acadia Healthcare by 78.2% during the 3rd quarter. Prelude Capital Management LLC now owns 69,184 shares of the company’s stock worth $1,713,000 after buying an additional 30,369 shares during the period. Public Employees Retirement System of Ohio lifted its holdings in Acadia Healthcare by 2.8% during the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock worth $776,000 after acquiring an additional 867 shares in the last quarter. Finally, Invenomic Capital Management LP grew its stake in Acadia Healthcare by 41.6% in the third quarter. Invenomic Capital Management LP now owns 1,936,396 shares of the company’s stock valued at $47,945,000 after acquiring an additional 568,796 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.